Independence of HIF1a and androgen signaling pathways in prostate cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Independence of HIF1a and androgen signaling pathways in prostate cancer
Authors
Keywords
-
Journal
BMC CANCER
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-25
DOI
10.1186/s12885-020-06890-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hypoxia induces rapid changes to histone methylation and reprograms chromatin
- (2019) Michael Batie et al. SCIENCE
- Hypoxia/pseudohypoxia‐mediated activation of hypoxia‐inducible factor‐1α in cancer
- (2019) Yoshihiro Hayashi et al. CANCER SCIENCE
- Stable H3K4me3 is associated with transcription initiation during early embryo development
- (2019) Xin Huang et al. BIOINFORMATICS
- Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer
- (2018) Lingjian Yang et al. EBioMedicine
- The association of HIF-1α expression with clinicopathological significance in prostate cancer: a meta-analysis
- (2018) Meng Huang et al. Cancer Management and Research
- Interplay between hypoxia and androgen controls a metabolic switch conferring resistance to androgen/AR-targeted therapy
- (2018) Hao Geng et al. Nature Communications
- Is H3K4me1 at enhancers correlative or causative?
- (2017) Alvaro Rada-Iglesias NATURE GENETICS
- Androgen receptor signaling in castration-resistant prostate cancer: a lesson in persistence
- (2016) Isabel Coutinho et al. ENDOCRINE-RELATED CANCER
- Mécanismes de résistance à la castration : l’hypoxie intratumorale stimule l’expression du récepteur aux androgènes
- (2016) P. Lunardi et al. PROGRES EN UROLOGIE
- Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting
- (2016) E S Antonarakis et al. PROSTATE CANCER AND PROSTATIC DISEASES
- The HIF/PHF8/AR axis promotes prostate cancer progression
- (2016) D Tong et al. Oncogenesis
- Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer
- (2015) Masaki Shiota et al. ENDOCRINE-RELATED CANCER
- HIF1α Expression under Normoxia in Prostate Cancer— Which Pathways to Target?
- (2015) Weranja K.B. Ranasinghe et al. JOURNAL OF UROLOGY
- Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study
- (2015) H. Ross-Adams et al. EBioMedicine
- Global Transcriptome Analysis of Formalin-Fixed Prostate Cancer Specimens Identifies Biomarkers of Disease Recurrence
- (2014) Q. Long et al. CANCER RESEARCH
- Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer
- (2014) V. Zecchini et al. EMBO JOURNAL
- The ETS family member GABPα modulates androgen receptor signalling and mediates an aggressive phenotype in prostate cancer
- (2014) Naomi L. Sharma et al. NUCLEIC ACIDS RESEARCH
- ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients
- (2013) E. Baena et al. GENES & DEVELOPMENT
- The Role of Hypoxia-Inducible Factor 1α in Determining the Properties of Castrate-Resistant Prostate Cancers
- (2013) Weranja K. B. Ranasinghe et al. PLoS One
- Genomic Interaction Profiles in Breast Cancer Reveal Altered Chromatin Architecture
- (2013) Michael J. Zeitz et al. PLoS One
- Hypoxia enhances ligand-occupied androgen receptor activity
- (2012) Choa Park et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Tumor Hypoxia Predicts Biochemical Failure following Radiotherapy for Clinically Localized Prostate Cancer
- (2012) M. Milosevic et al. CLINICAL CANCER RESEARCH
- High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq
- (2011) J. Schodel et al. BLOOD
- The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
- (2011) Charles E Massie et al. EMBO JOURNAL
- Characterising the castration-resistant prostate cancer population: a systematic review
- (2011) M. Kirby et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- ChIPpeakAnno: a Bioconductor package to annotate ChIP-seq and ChIP-chip data
- (2010) Lihua J Zhu et al. BMC BIOINFORMATICS
- The cost of reducing starting RNA quantity for Illumina BeadArrays: A bead-level dilution experiment.
- (2010) Andy G Lynch et al. BMC GENOMICS
- Coordinate Transcriptional Regulation by ERG and Androgen Receptor in Fusion-Positive Prostate Cancers
- (2010) Yu Chen et al. CANCER CELL
- An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression
- (2010) Jindan Yu et al. CANCER CELL
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- Hypoxia enhances transcriptional activity of androgen receptor through hypoxia-inducible factor-1α in a low androgen environment
- (2010) Takakazu Mitani et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Castration resistance of prostate cancer cells caused by castration-induced oxidative stress through Twist1 and androgen receptor overexpression
- (2009) M Shiota et al. ONCOGENE
- Phosphorylation of the androgen receptor is associated with reduced survival in hormone-refractory prostate cancer patients
- (2008) P McCall et al. BRITISH JOURNAL OF CANCER
- Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study
- (2008) Roy Vergis et al. LANCET ONCOLOGY
- Hypoxia induces a novel signature of chromatin modifications and global repression of transcription
- (2008) Amber Buescher Johnson et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Genome-Scale Validation of Deep-Sequencing Libraries
- (2008) Dominic Schmidt et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started